advertisement
11.4 Prostaglandins (113)
Showing records 1 to 25
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins69287 Effects of Brinzolamide, a Topical Carbonic Anhydrase Inhibitor, on Corneal Endothelial Cells
Nakano T
Advances in Therapy 2016; 33: 1452-1459
69143 Preservative-free tafluprost in the treatment of open-angle glaucoma or ocular hypertension in India: a phase III clinical trial
Chabi A
International Journal of Clinical Pract 2016; 70: 577-586
68907 Validity of the Monocular Trial of Intraocular Pressure-Lowering at Different Time Points in Patients Starting Topical Glaucoma Medication
King AJ
JAMA ophthalmology 2016; 134: 742-747
69206 PTGFR and SLCO2A1 Gene Polymorphisms Determine Intraocular Pressure Response to Latanoprost in Han Chinese Patients with Glaucoma
Zhang P
Current Eye Research 2016; 0: 1-5
69023 Tafluprost Ophthalmic Solution 0.0015Â %: A Review in Glaucoma and Ocular Hypertension
Keating GM
Clinical Drug Investigation 2016; 36: 499-508
69392 Efficacy of Latanoprostene Bunod 0.024% Compared With Timolol 0.5% in Lowering Intraocular Pressure Over 24 Hours
Liu JH
American Journal of Ophthalmology 2016; 169: 249-257
69177 Latanoprost and Dorzolamide for the Treatment of Pediatric Glaucoma: The Glaucoma Italian Pediatric Study (Gipsy), Design and Baseline Characteristics
Quaranta L
Advances in Therapy 2016; 33: 1305-1315
69257 Ocular hypotensive effect of fixed-combination brinzolamide/brimonidine adjunctive to a prostaglandin analog: a randomized clinical trial
Fechtner RD
Eye 2016; 30: 1343-1350
68929 The impact of chronic use of prostaglandin analogues on the biomechanical properties of the cornea in patients with primary open-angle glaucoma
Meda R
British Journal of Ophthalmology 2017; 101: 120-125
69393 Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study
Kawase K
Advances in Therapy 2016; 33: 1612-1627
69119 Long-term assessment of prostaglandin analogs and timolol fixed combinations vs prostaglandin analogs monotherapy
Liu AW
International Journal of Ophthalmology 2016; 9: 750-756
68837 Clicking Eyelids: A New Finding of Prostaglandin-Associated Periorbitopathy
Skorin L
Optometry and Vision Science 2016; 93: 779-781
68922 Six-Month Intraocular Pressure Reduction with a Topical Bimatoprost Ocular Insert: Results of a Phase II Randomized Controlled Study
Brandt JD
Ophthalmology 2016; 123: 1685-1694
68970 Changes in Corneal Biomechanical Properties after Long-Term Topical Prostaglandin Therapy
Wu N
PLoS ONE 2016; 11: e0155527
69195 Prostaglandin EP2 receptor signaling protects human trabecular meshwork cells from apoptosis induced by ER stress through down-regulation of p53
Kalouche G
Biochimica et Biophysica Acta 2016; 1863: 2322-2332
68991 Irregularly luscious lashes: difficult to say but a sinister sign to miss
Hamroush A
British Medical Journal (Clinical Research Edition) Case Reports 2016; 2016:
69207 Subconjunctival Delivery of Dorzolamide-Loaded Poly(ether-anhydride) Microparticles Produces Sustained Lowering of Intraocular Pressure in Rabbits
Fu J
Molecular pharmaceutics 2016; 13: 2987-2995
69141 Long-term topical application of preservative-free prostaglandin analogues evokes macrophage infiltration in the ocular adnexa
Trzeciecka A
European Journal of Pharmacology 2016; 788: 12-20
69107 Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma
Walimbe T
Clinical Ophthalmology 2016; 10: 821-827
69203 Evaluation of physical properties and dose equivalency of generic versus branded latanoprost formulations
Angmo D
International Ophthalmology 2017; 37: 423-428
69172 Preservative-free versus preserved latanoprost eye drops in patients with open-angle glaucoma or ocular hypertension
Aptel F
Current Medical Research and Opinion 2016; 32: 1457-1463
69482 Intraocular pressure dynamics with prostaglandin analogs: a clinical application of the water-drinking test
Özyol P
Clinical Ophthalmology 2016; 10: 1351-1356
69107 Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma
Chelerkar V
Clinical Ophthalmology 2016; 10: 821-827
68929 The impact of chronic use of prostaglandin analogues on the biomechanical properties of the cornea in patients with primary open-angle glaucoma
Wang Q
British Journal of Ophthalmology 2017; 101: 120-125
68970 Changes in Corneal Biomechanical Properties after Long-Term Topical Prostaglandin Therapy
Chen Y
PLoS ONE 2016; 11: e0155527
